125 related articles for article (PubMed ID: 10906876)
1. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma.
Shin KH; Moon SH; Suh JS; Yang WI
Clin Orthop Relat Res; 2000 Jul; (376):200-8. PubMed ID: 10906876
[TBL] [Abstract][Full Text] [Related]
2. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.
Moon SH; Shin KH; Suh JS; Yang WI; Noh JK; Hahn SB
Yonsei Med J; 2005 Feb; 46(1):119-24. PubMed ID: 15744814
[TBL] [Abstract][Full Text] [Related]
3. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging.
Lawrence JA; Babyn PS; Chan HS; Thorner PS; Pron GE; Krajbich IJ
Radiology; 1993 Oct; 189(1):43-7. PubMed ID: 8372217
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma: chemotherapy-induced changes at MR imaging.
Holscher HC; Bloem JL; Vanel D; Hermans J; Nooy MA; Taminiau AH; Henry-Amar M
Radiology; 1992 Mar; 182(3):839-44. PubMed ID: 1535905
[TBL] [Abstract][Full Text] [Related]
6. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
Holscher HC; Bloem JL; van der Woude HJ; Hermans J; Nooy MA; Taminiau AH; Hogendoorn PC
Clin Radiol; 1995 Jun; 50(6):384-90. PubMed ID: 7789022
[TBL] [Abstract][Full Text] [Related]
7. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.
Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
[TBL] [Abstract][Full Text] [Related]
8. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
[TBL] [Abstract][Full Text] [Related]
9. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
[TBL] [Abstract][Full Text] [Related]
10. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J
AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673
[TBL] [Abstract][Full Text] [Related]
11. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
[TBL] [Abstract][Full Text] [Related]
13. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma.
Onikul E; Fletcher BD; Parham DM; Chen G
AJR Am J Roentgenol; 1996 Nov; 167(5):1211-5. PubMed ID: 8911182
[TBL] [Abstract][Full Text] [Related]
15. Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma?
Holscher HC; Hermans J; Nooy MA; Taminiau AH; Hogendoorn PC; Bloem JL
Skeletal Radiol; 1996 Jan; 25(1):19-24. PubMed ID: 8717114
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
18. Tumor size and prognosis in aggressively treated osteosarcoma.
Bieling P; Rehan N; Winkler P; Helmke K; Maas R; Fuchs N; Bielack S; Heise U; Jurgens H; Treuner J; Romanowski R; Exner U; Kotz R; Winkler K
J Clin Oncol; 1996 Mar; 14(3):848-58. PubMed ID: 8622033
[TBL] [Abstract][Full Text] [Related]
19. Correlation between fluid-fluid levels on initial MRI and the response to chemotherapy in stage IIb osteosarcoma.
Jeon DG; Cho WH; Song WS; Kong CB; Cho SH; Lee JW; Lee SY
Ann Surg Oncol; 2014 Jun; 21(6):1956-62. PubMed ID: 24577812
[TBL] [Abstract][Full Text] [Related]
20. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]